•
Mar 31
Quest Diagnostics Q1 2025 Earnings Report
Quest Diagnostics posted strong revenue and earnings growth in the first quarter of 2025.
Key Takeaways
Quest Diagnostics saw a 12.1% increase in revenue and reported a higher net income, driven by acquisitions, enterprise demand, and growth in advanced diagnostics services.
Revenue rose 12.1% year-over-year to $2.65 billion.
Adjusted EPS reached $2.21, up from $2.04 a year ago.
Net income increased to $220 million from $194 million.
Organic requisition volume declined by 0.9% despite overall volume growth.
Quest Diagnostics
Quest Diagnostics
Quest Diagnostics Revenue by Segment
Forward Guidance
Quest reaffirmed its full-year 2025 guidance, anticipating steady revenue growth and consistent adjusted EPS range.
Positive Outlook
- Full-year revenue expected between $10.70B and $10.85B.
- Adjusted EPS forecast remains between $9.55 and $9.80.
- Cash from operations projected at $1.5B.
- Positive momentum from acquisitions and enterprise accounts.
- Expansion in health plan access driving demand.
Challenges Ahead
- Organic requisition volumes declined in Q1.
- Early quarter impacted by adverse weather.
- Net interest expense increased to $67M from $43M YoY.
- Cash position dropped to $188M from $549M.
- No upward revision to adjusted EPS despite strong Q1.